stella
beta
Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab — Stella
Recruiting
Back to Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Peking University Cancer Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov